<DOC>
	<DOC>NCT00127296</DOC>
	<brief_summary>This trial is conducted in the United States of America (USA). The aim of this trial is to compare desired (target) with actual target amounts of insulin dispensed using NovoLog速 Mix 70/30 FlexPen速 and vial and syringe in subjects with type 2 diabetes mellitus. No insulin is administered in this trial - insulin is dispensed into an empty vial.</brief_summary>
	<brief_title>Reliability of Dosing With NovoLog速 Mix 70/30 FlexPen速 Compared With Vial and Syringe</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Type 2 diabetes Insulin naive No previous experience administering injections Any condition that, in the Investigator and/or Sponsor's opinion, could interfere with the results of this trial</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>